671 Search Results for: new to drug testing
Dangers of synthetic cannabinoids
Synthetic cannabinoids change frequently and Quest works to stay current with drug-use patterns by adding compounds to our drug test panels.
Busting the top 10 marijuana myths
The Drug & Alcohol Testing Industry Association developed a brochure that highlights the common myths surrounding marijuana use.
Workplace opioid use is costing employers
A Wall Street Journal article highlights the impact of employees' heroin and opioids use in the workplace, citing recent Drug Testing Index data.
October is National Substance Abuse Prevention Month
In 2011, President Obama issued the Presidential Proclamation designating October as National Substance Abuse Prevention Month.
Webinar insights: Tracking the trends
Dr. Barry Sample, Director of Science and Technology, reviewed key data and insights from the Quest Diagnostics Drug Testing Index.
Positivity is up for the first time in a decade
After years of declines, the prevalence of positive workforce drug tests is increasing according to the Quest Diagnostics Drug Testing Index data.
2014 SAPAA conference
As a platinum sponsor of the SAPAA conference, we couldn't be more excited about this gathering of thought leaders and experts from the industry.
Ask the experts: Under the influence
Is oral fluid is the best drug test specimen type for determining whether an employee is under the influence of drugs – particularly marijuana?
Continuous lab improvements
Quest Diagnostics diligently focuses on our laboratories and continually adjusts, refines and improves our testing processes.
Prescription opioids: A dose of reality
Prescription drug abuse is the nation's fastest-growing drug problem and has been classified as an epidemic by the CDC.
